High Prevalence Of Tuberculosis In North America Is Propelling The Growth Of The Pyrazinamide Market

Pyrazinamide Market


 In March 2017, Médecins Sans Frontières (MSF), Partners In Health (PIH), and other medical organizations have launched a major clinical trial that seeks to revolutionize treatment for the toughest strains of tuberculosis (TB), the world’s leading infectious disease killer.

The increasing incidence and prevalence of tuberculosis (TB) disease is playing a significant role in the overall development of the Pyrazinamide market. According to the World Health Organization, worldwide, TB is one of the top 10 causes of death and the leading cause from a single infectious agent (above HIV/AIDS).In 2019, an estimated 10 million people fell ill with tuberculosis (TB) worldwide. 5.6 million men, 3.2 million women, and 1.2 million children. TB is present in all countries and age groups. Pyrazinamide is a drug widely used to treat tuberculosis. Furthermore, increasing spending on pharmaceutical industry by key manufacturers are further anticipated to uplift the growth of the Pyrazinamide market.

Pyrazinamide belongs to an extensive family of antifungal agents which include nystatin, anthrallin, and streptomycin.  It belongs to the group of antifungals known as antifungal agents that inhibit the growth of filamentous organisms such as yeast, mold, and algae. It is used to treat tuberculosis (TB) Pyrazinamide comes in tablet form and can also be given as a nasal spray or lozenge. Pyrazinamide, like many antifungals, acts by inhibiting the replication of the causative agent, the bacteria. Therefore, when the causative agent, a gram-negative bacteria, is not reproduced rapidly, the infection will be under control. Like many antifungals, pyrazinamide may be taken by mouth in liquid or tablet form.

From the geographical analysis, North America is projected to attain tremendous growth over the forecast timeframe owing to the strong presence of the healthcare industry due to growing investment by the government in the region. As per the stats published by the U.S. Centers for Medicare & Medicaid Services, the U.S. health care spending grew 4.6 percent in 2019, reaching $3.8 trillion or $11,582 per person. As a share of the nation's Gross Domestic Product, health spending accounted for 17.7 percent. Moreover, the high prevalence of tuberculosis in the region has further boosted the regional market growth in recent years.

Major Players:

Key players engaged in the global pyrazinamide market are Pure Chemistry Scientific, TCI, HBCChem, LGM Pharma, Toronto Research Chemicals, Alfa Chemistry, Acros Organics, AlliChem, Waterstone Technology, and, City Chemical.

Comments

Post a Comment

Popular posts from this blog

Bourbon Whiskey Is the Most Popular Whiskey in America and In Many Other Countries around the World

Image
  Whiskey or single malt whiskey is simply a form of distilled beverage made by distilling alcohol from grain mash or even by blending both. Different grains are utilized for different types, such as corn, barley, rye, and wheat. In Scotland, they call their whiskey black tea, a lighter caramel scotch, Irish cream, and liqueur. Whichever form is utilized, the result is usually a flavorful and smooth drink that has a distinct taste, and many people prefer a whiskey with a lower alcohol content. For example, single malt whiskey is the least expensive. The highest price however is the least distilled; that is Bourbon whiskey. Bourbon whiskey is the most popular whiskey in America and in many other countries around the world. Its price range is very wide, starting from as low as about US$ 12 a bottle to over a hundred dollars. So the price definitely varies. Whichever class you belong to, there is always a whiskey that will suit your preference. Single malt scotch whiskey is made ...
Read more

Viral Vectors And Plasmid DNA Manufacturing Market Is Gaining Major Traction With Oxford Biomedica Plc Entering Into A 3-Year Agreement With Boehringer Ingelheim For The Manufacture And Supply Of Various Types Of Viral Vectors

Image
  Viral Vectors are proteins that have been discovered to be essential for the spread of various viruses and infectious agents. These proteins can cause serious health risks if they are improperly introduced or if a wrong agent is used to fight them off. Viral vectors have often been used in various gene therapy procedures with the ultimate objective of curing various ailments in the biological fields of neurology, gene therapy, cancer, and metabolic disorder. Clinical studies regarding viral vectors remain one of the key factors in the manufacturing of viral vectors. Plasmids are used to deliver DNA contain genes for antibiotic resistance. In fact, scientists have developed many uses of plasmids and created software to record the DNA sequences of plasmids for applications in various techniques. Thus, such continuous R&D activities can potentially stimulate growth of the viral vectors and plasmid DNA manufacturing market . Recently, in April 2021, Oxford Biomedica plc entered...
Read more

Hard Surface Flooring Market Is Expected To Witness Robust Growth As Mohawk Industries Introduces Newly Imagined 30,000-Square Foot Floor Space At The International Surface Event (TISE)

Image
  There are many reasons why people choose hard surface floors over other types of flooring. Hard surfaces offer a level of durability and are very aesthetically pleasing. Unfortunately, choosing this type of flooring can be confusing and costly. There are four main hard surface varieties namely vinyl plank, laminate, solid hardwood, and engineered wood. Each has their own style strengths and provide different advantages. Increasing population coupled with rapid urbanization is expected to drive growth of the global hard surface flooring market . According to the United Nations (UN), by 2050, around 68% of the global population is expected to live in urban areas, increasing from 55% in 2018. According to the same source, in 2018, around 4.2 billion people were living in urban areas, increasing from 751 million in 1950. Furthermore, according to the World Bank, in 2019, the global population reached 7.674 billion, increasing from 6.84 billion in 2009. As a result of this, building...
Read more